A study at Charité – Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient…

Application period ends on May 28

Joint press release by Charité and Max Delbrück Center

Nature study: MIS-C traced to reactivation of the Epstein-Barr virus

MotorSkins launches new project with BORN Germany and The Smart Textiles Hub to develope wearable technology for dynamic compression for mental health management

New treatment approach for rare blood cancer in the skin

LUM GmbH and Alpharmaca Inc. start working together in February

GQ Bio announces that it has been acquired by Pacira.

Analysis confirms outstanding quality standards at Charité – Universitätsmedizin Berlin

Company to divest its Vascular Intervention Business Division to Teleflex Inc.